Literature DB >> 35397680

Colorectal liver metastases: state-of-the-art management and surgical approaches.

Timothy E Newhook1, Jean-Nicolas Vauthey2.   

Abstract

BACKGROUND: The liver is the most common site of metastasis for patients with colorectal cancer, and resection is associated with significantly improved survival for selected patients. Advancements in perioperative care, operative technique, and multidisciplinary management have led to improved outcomes for patients with colorectal liver metastases (CLM).
PURPOSE: This review discusses recent advances in perioperative management, patient selection and prognostication, and surgical technique that make up the state-of-the-art management for patients with CLM.
CONCLUSION: Novel approaches to prognostication and measurement of treatment response, such as tumor somatic mutational profiling and circulating tumor DNA (ctDNA), are revolutionary instruments for patient selection and treatment sequence. Further, refinements to surgical approaches for patients with bilateral CLM, including two-stage hepatectomy (TSH), are available for these patients and may lead to improved surgical outcomes. The advances discussed in this review will result in more patients being considered for resection and refined selection for perioperative care strategies that will lead to improved survival for patients with CLM.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Colorectal liver metastases; Hepatectomy; Metastatic colorectal cancer; State of the art; ctDNA

Mesh:

Year:  2022        PMID: 35397680     DOI: 10.1007/s00423-022-02496-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  90 in total

1.  Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Mustafa A Arain; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Linda Farkas; Ignacio Garrido-Laguna; Jean L Grem; Andrew Gunn; J Randolph Hecht; Sarah Hoffe; Joleen Hubbard; Steven Hunt; Kimberly L Johung; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Eric D Miller; Mary F Mulcahy; Steven Nurkin; Michael J Overman; Aparna Parikh; Hitendra Patel; Katrina Pedersen; Leonard Saltz; Charles Schneider; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Kristina M Gregory; Lisa A Gurski
Journal:  J Natl Compr Canc Netw       Date:  2021-03-02       Impact factor: 11.908

2.  Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases.

Authors:  Michael D'Angelica; Peter Kornprat; Mithat Gonen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2010-11-02       Impact factor: 5.344

3.  A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

Authors:  M Ychou; W Hohenberger; S Thezenas; M Navarro; J Maurel; C Bokemeyer; E Shacham-Shmueli; F Rivera; C Kwok-Keung Choi; A Santoro
Journal:  Ann Oncol       Date:  2009-06-30       Impact factor: 32.976

4.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

5.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

6.  Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.

Authors:  Guillaume Portier; Dominique Elias; Olivier Bouche; Philippe Rougier; Jean-François Bosset; Jean Saric; Jacques Belghiti; Pascal Piedbois; Rosine Guimbaud; Bernard Nordlinger; Roland Bugat; Franck Lazorthes; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

Review 7.  The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis.

Authors:  Yoshikuni Kawaguchi; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2020-08-14       Impact factor: 5.344

8.  Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Lynette Cederquist; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Evan Wuthrick; Kristina M Gregory; Lisa Gurski; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-07       Impact factor: 11.908

9.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

10.  Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.

Authors:  Kiyoshi Hasegawa; Akio Saiura; Tadatoshi Takayama; Shinichi Miyagawa; Junji Yamamoto; Masayoshi Ijichi; Masanori Teruya; Fuyo Yoshimi; Seiji Kawasaki; Hiroto Koyama; Masaru Oba; Michiro Takahashi; Nobuyuki Mizunuma; Yutaka Matsuyama; Toshiaki Watanabe; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

View more
  1 in total

1.  Store-Operated Ca2+ Entry Is Up-Regulated in Tumour-Infiltrating Lymphocytes from Metastatic Colorectal Cancer Patients.

Authors:  Pawan Faris; Agnese Rumolo; Laura Tapella; Matteo Tanzi; Alessia Metallo; Filippo Conca; Sharon Negri; Konstantinos Lefkimmiatis; Paolo Pedrazzoli; Dmitry Lim; Daniela Montagna; Francesco Moccia
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.